Murray Stewart

Insider Reports History

Location
Boston, MA
Signature
/s/ David Kirske, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Murray Stewart:

Company Role Class Num Shares Value Price $ Report Date Ownership
AMARIN CORP PLC\UK Director Stock Option (Right to Buy) 223,560 $241,445 $1.08 09 Jan 2023 Direct
X4 Pharmaceuticals, Inc Director Common Stock 7,883 $1,497 $0.1900 09 Jun 2025 Direct
AMARIN CORP PLC\UK Director Restricted Stock Units 182,433 09 Jan 2023 Direct
Camp4 Therapeutics Corp Director Stock Option (Right to Buy) 17,787 17 Mar 2025 Direct
X4 Pharmaceuticals, Inc Director Stock Option (right to buy) 0 01 Jan 2026 Direct

Insider Reports Filed by Murray Stewart

Symbol Company Period Transactions Value $ Form Type Role Filing Time
XFOR X4 Pharmaceuticals, Inc 01 Jan 2026 1 $0 4 Director 05 Jan 2026, 16:04
XFOR X4 Pharmaceuticals, Inc 09 Jun 2025 1 $0 4 Director 10 Jun 2025, 16:30
CAMP Camp4 Therapeutics Corp 17 Mar 2025 1 $0 4 Director 19 Mar 2025, 16:07
CAMP Camp4 Therapeutics Corp 17 Mar 2025 0 $0 3 Director 19 Mar 2025, 16:02
XFOR X4 Pharmaceuticals, Inc 10 Jun 2024 1 $0 4 Director 11 Jun 2024, 16:13
XFOR X4 Pharmaceuticals, Inc 09 Aug 2023 2 -$137,859 4 Interim Chief Medical Officer, Director 11 Aug 2023, 19:26
AMRN AMARIN CORP PLC\UK 09 Jan 2023 2 $0 4 Director 12 Jan 2023, 19:03
AMRN AMARIN CORP PLC\UK 09 Jan 2023 0 $0 3 Director 12 Jan 2023, 19:02
XFOR X4 Pharmaceuticals, Inc 06 Jun 2022 1 $0 4 Director 27 Jun 2022, 16:15
XFOR X4 Pharmaceuticals, Inc 02 Jun 2021 1 +$57,000 4 Director 02 Jun 2021, 17:03